Skip to main content
logo
Azenta, Inc. (AZTA)
NASDAQ: AZTA · Real-Time Price · USD
32.28
-0.11 (-0.34%)
At close: Oct 24, 2025, 4:00 PM EDT
32.39
+0.11 (0.34%)
After-hours: Oct 24, 2025, 7:25 PM EDT

Revenue by Geography

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212017 - 2020
Period Ending
Jun '25 Sep '24 Sep '23 Sep '22 Sep '21 2017 - 2020
United States Revenue
363.27M366.21M
Log In
Log In
Log In
Upgrade
North America Revenue
--
Log In
Log In
Log In
Upgrade
Africa Revenue
-61.96M
Log In
Log In
Log In
Upgrade
China Revenue
57.14M58.26M
Log In
Log In
Log In
Upgrade
United Kingdom Revenue
33.28M27.45M
Log In
Log In
Log In
Upgrade
Rest of Europe Revenue
106.11M102.77M
Log In
Log In
Log In
Upgrade
Asia Pacific/ Other Revenue
31.62M39.67M
Log In
Log In
Log In
Upgrade
Revenue (Other)
77.41M-
Log In
Log In
Log In
Upgrade
Revenue (Total)
668.82M656.32M
Log In
Log In
Log In
Upgrade

Revenue Breakdown

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212017 - 2020
Period Ending
Jun '25 Sep '24 Sep '23 Sep '22 Sep '21 2017 - 2020
Sample Management Solutions Revenue
323.65M318.65M
Log In
Log In
Log In
Upgrade
Multiomics Revenue
262.05M254.55M
Log In
Log In
Log In
Upgrade
B Medical Revenue
-83.13M
Log In
Log In
Log In
Upgrade
Revenue (Other)
83.13M-
Log In
Log In
Log In
Upgrade
Revenue (Total)
668.82M656.32M
Log In
Log In
Log In
Upgrade

Revenue Breakdown 2

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212017 - 2020
Period Ending
Jun '25 Sep '24 Sep '23 Sep '22 Sep '21 2017 - 2020
Life Sciences Products Revenue
--
Log In
Log In
Log In
Upgrade
Life Sciences Services Revenue
--
Log In
Log In
Log In
Upgrade
Revenue (Total)
668.82M656.32M
Log In
Log In
Log In
Upgrade

Revenue Breakdown 3

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212017 - 2020
Period Ending
Jun '25 Sep '24 Sep '23 Sep '22 Sep '21 2017 - 2020
Multiomics Revenue
262.05M254.55M
Log In
Log In
Log In
Upgrade
Core Products Revenue
196.98M196.73M
Log In
Log In
Log In
Upgrade
Sample Repository Solutions Revenue
126.67M121.91M
Log In
Log In
Log In
Upgrade
B Medical Revenue
-83.13M
Log In
Log In
Log In
Upgrade
Revenue (Total)
668.82M656.32M
Log In
Log In
Log In
Upgrade

Adjusted EBIT

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212017 - 2020
Period Ending
Jun '25 Sep '24 Sep '23 Sep '22 Sep '21 2017 - 2020
Sample Management Solutions Adjusted Operating Income
28.26M10.84M
Log In
Log In
Log In
Upgrade
Multiomics Adjusted Operating Income
-11.80M-8.00M
Log In
Log In
Log In
Upgrade
B Medical Systems Adjusted Operating Income
--5.67M
Log In
Log In
Log In
Upgrade
Operating Income (Other)
-86.47M-197.86M
Log In
Log In
Log In
Upgrade
Operating Income (Total)
-70.02M-200.68M
Log In
Log In
Log In
Upgrade

Adjusted EBIT 2

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212017 - 2020
Period Ending
Jun '25 Sep '24 Sep '23 Sep '22 Sep '21 2017 - 2020
Life Sciences Product Adjusted Operating Income
--
Log In
Log In
Log In
Upgrade
Life Sciences Services Adjusted Operating Income
--
Log In
Log In
Log In
Upgrade
Operating Income (Total)
-70.02M-200.68M
Log In
Log In
Log In
Upgrade

Key Performance Indicators

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212017 - 2020
Period Ending
Jun '25 Sep '24 Sep '23 Sep '22 Sep '21 2017 - 2020
Organic Revenue Growth
--2.00%
Log In
Log In
Log In
Upgrade
Updated Aug 5, 2025. Data Source: Fiscal.ai.